Seaview Investment Managers LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Seaview Investment Managers LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 23.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,275 shares of the healthcare conglomerate’s stock after acquiring an additional 3,653 shares during the period. UnitedHealth Group comprises 3.0% of Seaview Investment Managers LLC’s holdings, making the stock its 11th biggest position. Seaview Investment Managers LLC’s holdings in UnitedHealth Group were worth $9,816,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Aveo Capital Partners LLC lifted its stake in shares of UnitedHealth Group by 23.8% in the 4th quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock valued at $1,139,000 after purchasing an additional 416 shares during the period. 9258 Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 7.3% in the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after purchasing an additional 290 shares during the period. Gryphon Financial Partners LLC lifted its stake in shares of UnitedHealth Group by 80.9% in the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock valued at $3,275,000 after purchasing an additional 2,782 shares during the period. Jump Financial LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $1,695,000. Finally, USA Financial Formulas acquired a new position in UnitedHealth Group during the fourth quarter worth $87,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.5 %

Shares of UNH opened at $594.10 on Tuesday. The stock has a market capitalization of $548.60 billion, a PE ratio of 36.31, a P/E/G ratio of 1.66 and a beta of 0.58. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. The company’s 50-day simple moving average is $560.97 and its 200-day simple moving average is $515.54.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.14 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Analyst Ratings Changes

UNH has been the subject of a number of research analyst reports. Wells Fargo & Company upped their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. JPMorgan Chase & Co. upped their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research report on Thursday, May 30th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.